Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 27, 2019

The main goals with conducting clinical studies, which could include observational studies or clinical trials, are to explore the causes of a disease or its symptoms, test a treatment, and learn how a certain behaviour affects patients’ health. AI-Powered search platform maximizes access to publications.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 240

Chronic Pain Therapy Patients Topical 240

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 250

Clinical Trials Chronic Pain Cannabinoids Patients 250

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. Music by Desca.

Data 52

Data Patients Access Wellness and Beauty 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

SpeedWeed

MAY 28, 2021

This move to sign HB 89 is in line with recently published data that shows autism spectrum disorder can be treated with cannabis safely and with favorable results. The patients underwent the treatment for six months and provided feedback about their experience. The ratio they used was 30 percent CBD and 1.5 View original article.

Programs 52

Programs Research and Development Patients Safety 52

Peninsula Alternative Health

MARCH 1, 2018

Check out this comprehensive list by Peninsula Alternative Health in Salisbury, Maryland: Americans for Safe Access (ASA). based nonprofit and Americans for Safe Access Foundation “share the mission of ensuring safe and legal access to cannabis.for therapeutic use and research,” according to its website. This Washington, D.C.-based

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

Check out this comprehensive list by Peninsula Alternative Health in Salisbury, Maryland: Americans for Safe Access (ASA). based nonprofit and Americans for Safe Access Foundation “share the mission of ensuring safe and legal access to cannabis.for therapeutic use and research,” according to its website. This Washington, D.C.-based

Treatment 40

Treatment Education Advocacy Access 40

MedicalJane

DECEMBER 13, 2017

Introduced in July 2014, New York’s medical marijuana program has been a work in progress from the get-go. The state recently announced an expansion to its program that is beginning to open the door to improved patient access. Recent Updates to MMJ Program Aim to Improve Patient Access. Diane Savino (D-S.I.),

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. The Marijuana Regulatory Agency issued a request for proposals for the 2021 Veteran Marijuana Research Grant Program on Tuesday, June 1. Between Dec.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Senators Voted to Broaden Medical Cannabis Access for Veterans . Crescenz VA Medical Center.

Consumption 97

Consumption Research and Development Treatment Programs 97

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” The bill allocates $2 million for the grant program.

Legislation 97

Legislation Treatment Therapy Conditions 97

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment. The data is clear.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. “Numinus is glad to see Health Canada committing to broadened mental healthcare access, starting with those in most need,” said Payton Nyquvest, CEO of Numinus.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

The Cannigma

FEBRUARY 1, 2023

Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 7 The use of cannabis as a cancer treatment was popularized by Rick Simpson, a medical cannabis advocate. Use harm reduction techniques (i.e. Can cannabis fill this void?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Veriheal

AUGUST 31, 2021

This year, we are happy to announce we are expanding our scholarship program and awarding $20,0000 in scholarships to 20 winners. . Major/Program: Business Management with a Minor in Cannabis Studies. Major/Program: Art. Major/Program: Business Administration. Major/Program: Nursing. Matthew Aaron Vogel .

Research and Development 116

Research and Development Supply Chain Programs Education 116

Veriheal

MAY 26, 2022

RoC also works to increase patients’ access to medical cannabis by helping U.S. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Eric Rahn, Managing Director. For more information, visit [link].

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Veriheal

AUGUST 31, 2022

These safe consumption sites are sanctioned spaces for people to consume their drugs under the supervision of trained staff while having access to sterile consumption equipment. Nonetheless, the data speaks differently. . The Research Letter. The research letter written by Dr. The Research Letter. 30, 2021, and Jan.

Consumption 104

Consumption Data Treatment Collective 104

Cannabis Law Report

MARCH 17, 2022

The Australian Criminal Intelligence Commission (ACIC) on Monday released the 15th report of its National Wastewater Drug Monitoring Program. tonnes of methylamphetamine, cocaine, MDMA and heroin was consumed in 2020-21, the fifth year of the Program. An estimated 15.7 The drop of approximately 4.7 An estimated 15.7

Consumption 52

Consumption Programs Data Treatment 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. Since the beginning of the program, medicinal cannabis has been prescribed for over 140 conditions.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

FEBRUARY 25, 2022

It is reasonably self-evident that the deduction from gross receipts for prescription drugs was similarly intended to make medical treatment more accessible, by lessening the expense to those who require it. The company said that it would receive a $7.4 million refund plus interest following the Supreme Court ruling. “It

Programs 52

Programs Collective Data Patients 52

Puff Puff Post

MARCH 21, 2019

On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-bound paclitaxel) for the treatment of locally advanced or metastatic triple-negative breast cancer (TNBC). s Keytruda and Bristol-Myers Squibb’s (BMS) Opdivo.

Data 92

Data Treatment Media Patients 92

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

JANUARY 4, 2022

Medical marijuana treatment centers like Gold Leaf are the only businesses currently authorized to cultivate, process, and dispense low-THC cannabis and medical marijuana in Florida. Cumulatively, all of the 10-year agreements under Agrify’s TTK Solution program are currently projected to generate an estimated $850 million in total revenue.

Extraction 52

Extraction Cultivation Programs Data 52